Analysts See $-2.71 EPS for Puma Biotechnology Inc (PBYI)

Alicia Farmer
November 9, 2017

Ecopetrol had 10 analyst reports since August 12, 2015 according to SRatingsIntel. The rating was maintained by UBS on Friday, November 20 with "Neutral". As per Wednesday, October 25, the company rating was maintained by RBC Capital Markets. The stock of Ecopetrol SA (ADR) (NYSE:EC) has "Hold" rating given on Friday, September 9 by Tudor Pickering. The company has a consensus rating of "Buy" and an average target price of $126.56. The stock has "Equal-Weight" rating by Morgan Stanley on Wednesday, May 31. Evercore downgraded the shares of BBY in report on Tuesday, November 8 to "Sell" rating.

Franklin Street Advisors Inc decreased its stake in Puma Biotechnology Inc (PBYI) by 23.33% based on its latest 2017Q2 regulatory filing with the SEC. Finally, Highbridge Capital Management LLC purchased a new stake in Puma Biotechnology during the third quarter worth $462,000. (PBYI)'s stock declined 6.09%. Puma Biotechnology Inc. now has $4.88B valuation. It closed at $129.9 lastly. About 319,637 shares traded. It has outperformed by 6.95% the S&P500. The company has market cap of $23.02 billion. The Company's divisions include Europe and AMAP. The Company's Exploration and Production segment includes exploration, development and production activities in Colombia and overseas. Its down 0.46, from 1.67 in 2017Q1. Another trade for 9,974 shares valued at $597,091 was sold by Walker Patricia H. Wetherby Asset Inc stated it has 0.03% of its portfolio in Ecopetrol SA (ADR) (NYSE:EC). First Manhattan reported 0% in Ecopetrol SA (ADR) (NYSE:EC). National Bank Of America Corporation De holds 148,568 shares or 0% of its portfolio. JPMorgan Chase & Co. set a $89.00 price target on Puma Biotechnology and gave the company a "buy" rating in a research report on Monday, November 14th. Northwestern Mutual Wealth Management Com reported 700 shares stake. Wellington Mgmt Gp Llp reported 1.71M shares or 0.04% of all its holdings. Blackrock Incorporated has 1.83 million shares. Royal Commercial Bank Of Canada stated it has 2,953 shares or 0% of all its holdings. The company had a trading volume of 1,097,662 shares, compared to its average volume of 614,347. The original version of this piece of content can be accessed at https://www.truebluetribune.com/2017/11/09/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-puma-biotechnology-pbyi-stock-price.html. American International Group Inc. now owns 16,931 shares of the biopharmaceutical company's stock worth $630,000 after buying an additional 2,733 shares during the last quarter.

Puma Biotechnology Inc (NYSE:PBYI) institutional sentiment decreased to 1.21 in 2017 Q2. Its down 0.46, from 1.67 in 2017Q1.

Stock Indicator Focus for International Business Machines (IBM)
The technology company reported $3.30 earnings per share for the quarter, topping the Zacks' consensus estimate of $3.28 by $0.02. The expected future growth in earnings per share ("EPS") is an incredibly important factor.in identifying an under-valued stock.

Bob Goodlatte adds to the growing list of Republican House retirements
Goodlatte outlined a list of goals he'd like to achieve before leaving office, including immigration reform and ObamaCare repeal. Hensarling leads the House Financial Services Committee, while Smith leads the Science, Space and Technology panel.

Marvell Technology Group Ltd. (MRVL) Upgraded by Citigroup Inc. to Neutral
Citigroup Inc. cut shares of Marvell Technology Group to a "sell" rating in a research report on Saturday, November 19th. The stock of Marvell Technology Group Ltd . (NASDAQ:MRVL) has "Buy" rating given on Monday, November 6 by Cowen & Co.

Puma Biotechnology Inc (NYSE:PBYI) will be announcing its earnings results after the market closes on Thursday, November 9th. Sold All: 24 Reduced: 44 Increased: 39 New Position: 43. Legal General Grp Public Limited Co reported 0% of its portfolio in Puma Biotechnology Inc (NASDAQ:PBYI). Farallon Capital Mngmt Ltd Llc holds 0.19% in Puma Biotechnology Inc (NASDAQ:PBYI) or 213,000 shares. Rhumbline Advisers accumulated 33,733 shares. Cubist Systematic Strategies Ltd Liability Company owns 1,668 shares or 0.01% of their USA portfolio.

Wells Fargo & Company Mn invested 0% in Puma Biotechnology Inc (NASDAQ:PBYI). Aqr Mngmt Limited stated it has 0% of its portfolio in Puma Biotechnology Inc (NASDAQ:PBYI). Ameriprise Inc holds 0.01% or 164,104 shares. Switzerland-based Swiss Retail Bank has invested 0.01% in Puma Biotechnology Inc (NASDAQ:PBYI). 79,400 are held by Quantitative Investment Mgmt Ltd Liability Corporation. RBC Capital Markets reaffirmed a "sector perform" rating on shares of Puma Biotechnology in a research note on Wednesday, November 16th. Finally, BidaskClub upgraded shares of Puma Biotechnology from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, October 3rd. Therefore 91% are positive. PBYI was included in 44 notes of analysts from August 27, 2015. The firm has "Buy" rating by J.P. Morgan given on Tuesday, August 1. Credit Suisse maintained the stock with "Outperform" rating in Thursday, September 22 report. On Wednesday, July 19 the stock rating was maintained by Leerink Swann with "Buy". The company was maintained on Tuesday, July 18 by Credit Suisse. As per Monday, June 5, the company rating was maintained by RBC Capital Markets. The stock has "Overweight" rating by JP Morgan on Monday, October 3.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER